SENSEX NIFTY
You are here : Moneycontrol > Mutual Funds > Sector - Pharma & Healthcare > Reliance Mutual Fund > Reliance Pharma Fund (G)

Reliance Pharma Fund (G)

PLAN: Regular OPTIONS: Growth
139.200 3.27 (2.40%)

NAV as on 05 Feb, 2016

CRISIL MF RANK

Not Ranked

Riskometer

HIGH

HIGH

  • Principal at high risk.
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
ranking by CRISIL

Not Ranked

This scheme is not ranked by CRISIL (for quarter ended Nov 1999) since it does not fulfill certain eligibility criteria of CRISIL

View Top ranked funds in other categories

Benchmark Index:
 
View Historic Graph From     To     

Returns (NAV as on 05 Feb, 2016)

Period Returns (%) Rank #
1 mth -5.3 6
3 mth -6.1 6
6 mth -4.6 4
1 year 10.7 4
2 year 28.4 4
3 year 28.1 4
5 year 21.5 2

# Moneycontrol Rank within 6 Sector - Pharma & Healthcare Schemes.

Absolute Returns (in %)

Year Qtr 1 Qtr 2 Qtr 3 Qtr 4 Annual
2015 9.5 -4.4 14.2 -3.4 19.3
2014 3.5 10.8 25.0 3.4 48.5
2013 -6.3 5.4 3.2 14.6 20.5
2012 8.6 4.0 10.7 5.7 34.9
2011 -8.0 7.5 -7.5 -4.2 -11.6

View where it stands within its peers

* Returns over 1 year are Annualised

Performance

Fund returns v/s Category average (Sector - Pharma & Healthcare)

* Returns over 1 year are Annualised
  1 mth (%) 3 mth (%) 6 mth (%) 1 yr (%) 2 yr (%) 3 yr (%) 5yr (%)
Fund Returns -5.3 -6.1 -4.6 10.7 28.4 28.1 21.5
Category avg -4.2 -4.8 -5.2 10.8 28.9 28.9 22.6
Difference of Fund returns and Category returns -1.1 -1.3 0.6 -0.1 -0.5 -0.8 -1.1
Best of category -2.3 -3.5 -2.7 17.9 35.7 34.5 27.3
Worst of category -5.3 -6.1 -7.8 5.5 24.1 25.3 19.1
Benchmark returns # -3.7 -8.2 -7.7 -- -- -- --
Difference of Fund returns and Benchmark returns -1.6 2.1 3.1 10.7 28.4 28.1 21.5
# Benchmark Index: S&P BSE HEALTHCARE

Investment Info

Investment Objective

The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.

Scheme details

Fund Type Open-Ended
Investment Plan Growth
Launch date May 26, 2004
Benchmark S&P BSE HEALTHCARE
Asset Size (Rs cr) 1,270.93 (Sep-30-2015)
Minimum Investment Rs.5000
Last Dividend N.A. View Dividend History
Bonus N.A.
Fund Manager Sailesh Rajbhan
View performance of schemes managed by the Fund Manager
Notes N.A

Load Details

Entry Load N.A
Exit Load 1.00%
Load Comments Exit load - 1% if redeemed/switched out on or before completion of 1 yrs from the date of allotment.

Contact Details

Regd. Office One India Bulls Centre - Tower One, 11th & 12th floor, Jupiter Mills Compound, Elphinstone Road, Mumbai , 400013
Tel. No. 022-30994600
Fax No. 91 22 30414899
Email customer_care@reliancemutual.com
Website http://www.reliancemutual.com/

Peer Comparison

Sector - Pharma & Healthcare Crisil Rank Assets (Rs.cr)
3mth (%) 6mth (%) 1yr (%) 3yr (%) 5yr (%)
Reliance Pharma Fund (G) Not Ranked
1,270.93 -6.1 -4.6 10.7 28.1 21.5
SBI Pharma Fund (G) Not Ranked
569.96 -3.8 -3.3 16.3 33.2 27.3
UTI Pharma & Health (G) Not Ranked
273.46 -4.5 -7.8 5.5 25.3 19.1
SBI Pharma Fund - Direct (G) Not Ranked
104.26 -3.5 -2.7 17.9 34.5 --
Reliance Pharma Fund - Direct (G) Not Ranked
101.05 -5.9 -4.2 11.7 29.0 --
* Returns over 1 year are Annualised More »

Portfolio

Top Holdings (Dec 31, 15)

Equity Sector Value
(Rs cr)
Asset %
Abbott India Pharmaceuticals 194.79 13.90
Sanofi India Pharmaceuticals 143.92 10.27
Sun Pharma Pharmaceuticals 142.94 10.20
Cipla Pharmaceuticals 133.55 9.53
Divis Labs Pharmaceuticals 132.15 9.43
Dr Reddys Labs Pharmaceuticals 104.40 7.45
Lupin Pharmaceuticals 102.72 7.33
Ipca Labs Pharmaceuticals 91.23 6.51
Cadila Health Pharmaceuticals 79.04 5.64
Aurobindo Pharm Pharmaceuticals 62.64 4.47

Full Portfolio

Sector Allocation (Dec 31, 15)

Sector %

1-Year

HighLow

Pharmaceuticals 95.99 99.15 88.73
Miscellaneous 1.86 1.86 1.51

View All Sectors

Asset Allocation (%)(Dec 31, 15)

Equity 97.85
Others 0.59
Debt 0.00
Mutual Funds N.A
Money Market 1.09
Cash / Call 0.47

View All

Concentration

Holdings (%)
Top 5 53.33
Top 10 84.73
Sector (%)
Top 3 97.85

News & Videos

News

Messages & Community

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.